In addition, increasing evidence shows that HKDC1 may play oncogenic roles in cancers, such as lymphoma [21], liver cancer [22], breast cancer [23] and colorectal cancer [24], indicating that HKDC1 may serve as a therapeutic target in cancers. The gene discussed is HKDC1; the disease is breast carcinoma.